Suppr超能文献

验证后的通用 PedsQL 评分与效用值间映射算法在镰状细胞病个体中的应用。

Application of validated mapping algorithms between generic PedsQL scores and utility values to individuals with sickle cell disease.

机构信息

The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, 1959 NE Pacific Street, H-375Q, Box 357630, Seattle, WA, 98195-7630, USA.

Department of Hematology, St. Jude Children's Research Hospital, Memphis, USA.

出版信息

Qual Life Res. 2022 Sep;31(9):2729-2738. doi: 10.1007/s11136-022-03167-2. Epub 2022 Jun 17.

Abstract

PURPOSE

There is a paucity of empirically estimated health state utility (HSU) values to estimate health-related quality of life among individuals with sickle cell disease (SCD). This study aims to map the Pediatric Quality of Life Inventory generic core scales (PedsQL GCS) to HSUs for children and adolescents with SCD in the United States, using published algorithms, and to assess the construct validity of these HSUs against SCD-specific PedsQL scores.

METHODS

We used the published mapping algorithms identified in four published articles, in which the PedsQL GCS was mapped to either the EuroQol-5 Dimension 3-Level, Youth Version or the Child Health Utility 9-Dimension to obtain HSUs. We employed the algorithms to calculate HSUs for a sample of children and adolescents from the Sickle Cell Clinical Research and Intervention Program. To assess the construct validity of the mapped HSUs in SCD patients, we computed Spearman's correlation coefficient comparing the HSUs with the PedsQL SCD total score and separately with each PedsQL SCD dimension-specific score.

RESULTS

The mean mapped HSU across published algorithms was 0.792 (95% CI: 0.782-0.801). It was significantly higher among children aged 5-12 years than children aged 13-17 years. The Spearman's correlation coefficient for HSUs versus PedsQL SCD total scores was 0.64 (95% CI: 0.57-0.71). Correlations ranged from 0.40 (95% CI: 0.32-0.48) to 0.60 (95% CI: 0.54-0.66) for HSUs versus PedsQL SCD dimension-specific scores.

CONCLUSIONS

The existing mapping algorithms show acceptable construct validity in children and adolescents with SCD. Additional algorithms are needed for adults and for specific SCD comorbidities.

摘要

目的

目前用于评估镰状细胞病(SCD)患者健康相关生命质量的健康状态效用(HSU)值主要来自实证研究。本研究旨在使用已发表的算法,将美国 SCD 儿童和青少年人群的儿科生存质量量表核心通用维度(PedsQL GCS)与 HSU 进行匹配,并评估这些 HSU 与 SCD 特异性 PedsQL 评分的结构效度。

方法

我们使用了在四篇已发表的文章中确定的已发表映射算法,其中 PedsQL GCS 分别被映射到欧洲五维健康量表 3 级简表(EuroQol-5D 3L)或儿童健康效用 9 维度量表(Child Health Utility 9-Dimension,CHU9D),以获得 HSU 值。我们采用这些算法对 Sickle Cell Clinical Research and Intervention Program 中的 SCD 儿童和青少年样本进行了 HSU 计算。为了评估 SCD 患者中映射 HSU 的结构效度,我们计算了 Spearman 相关系数,比较了 HSU 与 PedsQL SCD 总分以及 PedsQL SCD 各维度特异性评分之间的相关性。

结果

使用已发表的所有算法计算得出的平均映射 HSU 值为 0.792(95%置信区间:0.782-0.801)。该值在 5-12 岁儿童中显著高于 13-17 岁儿童。HSU 与 PedsQL SCD 总分之间的 Spearman 相关系数为 0.64(95%置信区间:0.57-0.71)。HSU 与 PedsQL SCD 各维度特异性评分之间的相关性范围为 0.40(95%置信区间:0.32-0.48)至 0.60(95%置信区间:0.54-0.66)。

结论

现有的映射算法在 SCD 儿童和青少年中具有可接受的结构效度。对于成年人和特定的 SCD 合并症,需要进一步开发新的算法。

相似文献

1
Application of validated mapping algorithms between generic PedsQL scores and utility values to individuals with sickle cell disease.
Qual Life Res. 2022 Sep;31(9):2729-2738. doi: 10.1007/s11136-022-03167-2. Epub 2022 Jun 17.
2
Translation, transcultural adaptation, and validation of PedsQL 3.0 Sickle Cell Disease Module into Brazilian Portuguese.
Pediatr Blood Cancer. 2024 Apr;71(4):e30862. doi: 10.1002/pbc.30862. Epub 2024 Jan 29.
3
Health State Utilities for Sickle Cell Disease: A Catalog Prepared From a Systematic Review.
Value Health. 2022 Feb;25(2):276-287. doi: 10.1016/j.jval.2021.08.002. Epub 2021 Sep 4.
5
Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions.
Appl Health Econ Health Policy. 2023 Nov;21(6):949-965. doi: 10.1007/s40258-023-00836-2. Epub 2023 Oct 3.
6
Mapping PedsQL scores onto CHU9D utility scores: estimation, validation and a comparison of alternative instrument versions.
Qual Life Res. 2020 Mar;29(3):639-652. doi: 10.1007/s11136-019-02357-9. Epub 2019 Nov 19.
7
Depression and quality of life in children with sickle cell disease: the effect of social support.
BMC Psychiatry. 2015 Apr 11;15:78. doi: 10.1186/s12888-015-0461-6.
8
PedsQL™ Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity.
Pediatr Blood Cancer. 2014 Jan;61(1):171-7. doi: 10.1002/pbc.24776. Epub 2013 Sep 13.

引用本文的文献

1
Meeting the Challenges of Preference-Weighted Health-Related Quality-of-Life Measurement in Children.
Pharmacoeconomics. 2024 Jun;42(Suppl 1):3-8. doi: 10.1007/s40273-024-01383-x. Epub 2024 May 9.
2
Measuring health-related quality of life in children with suspected genetic conditions: validation of the PedsQL proxy-report versions.
Qual Life Res. 2024 Jun;33(6):1541-1553. doi: 10.1007/s11136-024-03623-1. Epub 2024 Mar 12.
4
Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease.
PLoS One. 2022 Apr 28;17(4):e0267448. doi: 10.1371/journal.pone.0267448. eCollection 2022.

本文引用的文献

1
Health State Utilities for Sickle Cell Disease: A Catalog Prepared From a Systematic Review.
Value Health. 2022 Feb;25(2):276-287. doi: 10.1016/j.jval.2021.08.002. Epub 2021 Sep 4.
3
Mapping PedsQL scores onto CHU9D utility scores: estimation, validation and a comparison of alternative instrument versions.
Qual Life Res. 2020 Mar;29(3):639-652. doi: 10.1007/s11136-019-02357-9. Epub 2019 Nov 19.
4
Preference-based measure of health-related quality of life and its determinants in sickle cell disease in Nigeria.
PLoS One. 2019 Nov 18;14(11):e0223043. doi: 10.1371/journal.pone.0223043. eCollection 2019.
5
Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease.
JAMA Netw Open. 2019 Nov 1;2(11):e1915374. doi: 10.1001/jamanetworkopen.2019.15374.
6
CE: Understanding the Complications of Sickle Cell Disease.
Am J Nurs. 2019 Jun;119(6):26-35. doi: 10.1097/01.NAJ.0000559779.40570.2c.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验